Healthcare Weekly News and Deals – April 6th, 2026
- Anthropic, backed by a $30 billion Series G, acquires stealth startup Coefficient Bio in a $400 million all-stock AI-biotech deal. AI leader Anthropic has acquired Coefficient Bio, a stealth-mode startup specializing in AI for biological research, in a transaction valued at approximately $400 million in stock. Coefficient Bio, founded just eight months ago by elite researchers from Genentech’s Prescient Design unit, was backed by the venture firm Dimension, which reportedly held a 50% stake in the company. The acquisition marks a significant vertical expansion for Anthropic, as the Coefficient team—including co-founders Nathan C. Frey and Samuel Stanton—will join its Healthcare and Life Sciences division. The deal aims to transform the Claude AI model into a specialized infrastructure for drug discovery and biopharma workflows, positioning Anthropic to compete directly with specialized AI-medicine firms in a market estimated to be worth over $100 B. (Link)
- Merit Medical (NASD: MMSI) strengthens oncology division with the strategic acquisition of Viewpoint Medical. Merit Medical (MMSI) has finalized its purchase of View Point Medical to expand its therapeutic oncology portfolio. The acquisition includes View Point’s steerable needle technology, which is critical for accessing difficult-to-reach tumors during biopsy and ablation procedures. This strategic tuck-in acquisition allows Merit to offer a more comprehensive suite of tools to interventional radiologists. Investors view this move as a way for Merit to maintain its growth trajectory in the high-value oncology market while utilizing its established sales force to drive rapid adoption of the new technology across global hospitals. (Link)
- Blackstone-backed AGS Health said to file for $500 million India IPO to capitalize on healthcare outsourcing demand. AGS Health, a leading provider of revenue cycle management services backed by private equity giant Blackstone, is reportedly filing for an Initial Public Offering (IPO) in India to raise approximately $500 million. This move allows Blackstone to partially exit its investment while providing AGS Health with the capital necessary to scale its technology-enabled services and global delivery model. The IPO highlights the robust investor appetite for healthcare IT outsourcing firms that utilize AI and automation to streamline clinical documentation and billing. By listing on the Indian exchanges, AGS Health aims to leverage its significant operational footprint in the region to attract both domestic and international institutional investors. (Link)
- Eli Lilly (NYSE: LLY) acquires Centessa Pharmaceuticals for $1.5 billion to advance sleep disorder treatments. Eli Lilly (LLY) has reached an agreement to acquire Centessa Pharmaceuticals in a deal valued at approximately $1.5 billion. The acquisition focuses on Centessa’s promising pipeline of orexin receptor agonists, which are being developed to treat narcolepsy and other sleep disorders. Lilly aims to leverage its global R&D infrastructure to accelerate these therapies through clinical trials. The deal reinforces Lilly’s commitment to expanding its neuroscience portfolio beyond Alzheimer’s and pain management. By acquiring Centessa, Lilly gains access to potentially best-in-class molecules that address a significant unmet need in the sleep medicine market. (Link)
- Quantum Health acquires CirrusMD while GE HealthCare (NASD: GEHC) completes acquisition of Intelerad. These deals highlight a massive shift toward integrated digital health ecosystems where navigation, virtual delivery, and diagnostic data management are seamlessly combined to improve patient outcomes and provider efficiency. (Link)
- Grovecourt Capital Partners portfolio company Premier Radiology Services acquires Global Imaging Solutions to bolster teleradiology subspecialty expertise. Premier Radiology Services has expanded its domestic footprint by acquiring Global Imaging Solutions. This deal, backed by Grovecourt Capital Partners, focuses on increasing the volume of subspecialty interpretations, such as musculoskeletal and neuroradiology, available to its clients. The acquisition comes at a time when the demand for remote diagnostic services is surging due to radiologist shortages. Premier Radiology aims to use this merger to provide faster turnaround times and higher-quality reports to rural hospitals and imaging centers that lack on-site specialists, reinforcing its position as a leading teleradiology provider. (Link)
- Office Ally, backed by Barings, Francisco Partners, and New Mountain Capital, acquires Jopari Solutions to scale electronic transaction processing. The acquisition expands Office Ally’s clearinghouse network by integrating Jopari’s capabilities in electronic billing, clinical attachments, and payment workflows. Together, the combined platform enhances interoperability and supports higher transaction volumes across provider and payer interactions. The deal strengthens Office Ally’s position in end-to-end healthcare transaction infrastructure. It also reflects a broader shift toward automation and streamlined administrative operations across the healthcare system. (Link)
- Jukebox Health acquires Braided Health to enhance AI-driven integrated care platforms for high-needs dual-eligible populations. Jukebox Health acquired Braided Health to expand its AI-driven integrated care platform for high-need, dual-eligible Medicare and Medicaid populations. The transaction combines Braided Health’s AI-powered care management technology with Jukebox’s in-home clinical services, enabling health plans to better identify risks and intervene earlier. By integrating care management workflows with real-time, in-home clinical insights, the platform aims to improve outcomes while reducing total cost of care for complex patient populations. (Link)
- Community Health Systems (NYSE: CYH) completes divestiture of Huntsville-based Crestwood Medical Center. The transaction combines Braided Health’s AI-powered care management technology with Jukebox’s in-home clinical services, enabling health plans to better identify risks and intervene earlier. By integrating care management workflows with real-time, in-home clinical insights, the platform aims to improve outcomes while reducing total cost of care for complex patient populations. The combined platform strengthens Jukebox’s ability to serve dual-eligible Medicare and Medicaid populations at scale. The deal reflects a broader push to modernize legacy care management systems through data-driven, home-based interventions. (Link)
- Virtual care platform OpenLoop Health acquires nutrition-focused startup Season Health to expand clinical service offerings. The acquisition adds Season Health’s nutrition therapy capabilities to OpenLoop’s telehealth infrastructure, enabling more comprehensive care across chronic conditions and weight management programs. OpenLoop, which supports a range of virtual care providers including GLP-1 platforms, can now integrate dietitian-led services directly into its clinical workflows. The deal strengthens its ability to offer more complete, end-to-end virtual care solutions. It also reflects a broader trend of telehealth platforms expanding into lifestyle-based interventions to improve patient outcomes. (Link)
- Sentinel Capital Partners portfolio company Catalyst MedTech acquires X3D to expand advanced imaging service capabilities. Catalyst MedTech, formerly known as TTG Imaging Solutions and a portfolio company of Sentinel Capital Partners, has acquired X3D. This acquisition enhances Catalyst MedTech’s portfolio of diagnostic imaging services, particularly in the realm of specialized 3D imaging technology and maintenance. Sentinel Capital continues to support Catalyst’s aggressive buy-and-build strategy to create a dominant national player in the refurbished medical equipment and imaging service market. The integration of X3D is expected to provide Catalyst with deeper technical expertise and a broader customer base among hospitals and independent diagnostic centers.(Link)
- Gyde acquires Avid Health to launch AI-enabled Medicare brokerage platform and expand market footprint. Gyde has successfully acquired Avid Health, marking the launch of a new AI-enabled brokerage platform specifically designed for the Medicare market. The acquisition combines Gyde’s technology with Avid Health’s distribution network to streamline the plan selection process for seniors. By utilizing AI to analyze patient data and plan benefits, the new platform aims to increase transparency and match beneficiaries with optimal coverage. This deal reflects the increasing application of automation and artificial intelligence in the insurance brokerage space to simplify complex regulatory environments and improve consumer decision-making.(Link)
- LongueVue Capital and Swaney Group Capital partner to invest in Apex Dental Laboratory Group to drive regional expansion. Private equity firm LongueVue Capital has partnered with Swaney Group Capital to make a significant growth investment in Apex Dental Laboratory Group. Apex is a leading provider of dental lab services, and this capital infusion is intended to support the company’s buy-and-build strategy across the United States. The investors aim to leverage Apex’s digital dentistry capabilities to consolidate a fragmented market of local dental labs. This investment highlights the continued interest of PE firms in the dental services organization (DSO) and ancillary dental technology sectors, focusing on operational scaling through technology.(Link)
- Vision Innovation Partners acquires Frederick Eye Institute to expand ophthalmic surgical platform in the Mid-Atlantic. Vision Innovation Partners, a leading ophthalmic platform, has acquired Frederick Eye Institute, a multi-specialty ophthalmology practice. This acquisition further solidifies Vision Innovation Partners’ presence in the Mid-Atlantic region, adding significant clinical and surgical capacity. The firm continues to pursue a consolidation strategy, acquiring high-quality practices to provide integrated eye care services ranging from routine exams to complex surgeries. By joining the platform, Frederick Eye Institute will benefit from enhanced administrative support and access to advanced diagnostic technology, reflecting the ongoing private equity-led consolidation trend within the ophthalmology sector.(Link)
Venture Deals and Other
- WHOOP raises $575 million in Series G funding at a $10.1 billion valuation to scale its wearable health platform. The round includes participation from high-profile athletes and celebrities such as LeBron James, Cristiano Ronaldo, Rory McIlroy, and Shane Lowry, alongside institutional investors including Collaborative Fund, Mayo Clinic, Mubadala Investment Company, and Qatar Investment Authority. The capital will support expansion of its subscription-based wearable platform focused on sleep, recovery, and performance, while accelerating product development, enhancing data-driven health insights, and scaling its global membership base, with a continued push into broader health monitoring capabilities and long-term growth initiatives. (Link)
- Ambient Clinical Analytics raises $5 million and appoints Brian Tufts as CEO to scale AWARE clinical AI platform. Ambient Clinical Analytics has successfully closed a $5 million funding round aimed at scaling its AWARE platform, a clinical decision support tool designed to reduce medical errors in high-acuity settings like the ICU. Alongside the investment, the company named Brian Tufts as its new CEO to lead the commercial expansion. The funding will be used to integrate more advanced AI capabilities and expand the platform’s footprint in hospitals globally. Ambient’s technology focuses on real-time data visualization to help clinicians make faster, more accurate decisions, addressing the critical need for burnout reduction and improved patient safety. (Link)
- Jimini Health raises $17 million in venture funding to expand its AI-driven behavioral health platform. Jimini Health has secured $17 million in a new funding round to accelerate the growth of its AI-powered mental health platform. The investment will be directed toward expanding the company’s therapist network and enhancing its AI tools that assist in patient monitoring and personalized treatment planning. Jimini Health focuses on providing scalable, evidence-based behavioral care by combining human expertise with machine learning. This round reflects the continued venture capital appetite for AI solutions that address the global shortage of mental health professionals and provide more accessible care options for patients. (Link)
- Insight Health raises $11 million to scale clinical AI agents for automated healthcare administrative tasks. Insight Health has raised $11 million in venture capital to further develop and deploy its clinical AI agents. These agents are designed to automate routine administrative tasks for healthcare providers, such as documentation, scheduling, and billing queries. By offloading these burdens from clinical staff, Insight Health aims to reduce provider burnout and improve operational efficiency within hospital systems. The funding will support the expansion of the engineering team and the commercialization of the platform. This investment highlights the trend of “narrow AI” solving specific, high-friction problems in healthcare administration. (Link)
- Naver D2SF makes strategic investment in Soundable to advance AI-based respiratory health monitoring technology. Naver D2SF, the startup investment arm of South Korean tech giant Naver, has made a strategic investment in Soundable. Soundable specializes in AI-driven sound analysis technology that monitors respiratory health through cough and breathing patterns captured via smartphones. This investment is part of Naver’s broader strategy to expand its digital health ecosystem and integrate advanced diagnostic tools into its consumer platforms. The funds will help Soundable refine its algorithms and seek regulatory approvals in international markets. The deal underscores the rising interest in non-invasive, remote monitoring technologies that leverage everyday devices for health screening. (Link)
- Long Tail secures growth investment to expand its technology-driven healthcare solutions and market reach. Long Tail has announced a new growth investment aimed at scaling its technology platform. While the specific dollar amount was not disclosed, the funding will be used to enhance the company’s product development and expand its sales and marketing efforts. Long Tail focuses on providing specialized software solutions that help healthcare organizations manage “long tail” data and niche operational challenges. This investment reflects a growing interest from venture and growth equity firms in specialized SaaS platforms that address specific inefficiencies within the healthcare value chain, rather than broad, general-purpose software. (Link)